BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18018806)

  • 1. Addiction treatment services and co-occurring disorders: the ASAM-PPC-2R taxonomy of program dual diagnosis capability.
    McGovern MP; Xie H; Acquilano S; Segal SR; Siembab L; Drake RE
    J Addict Dis; 2007; 26(3):27-37. PubMed ID: 18018806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent validity of the ASAM criteria in co-occurring disorders.
    Stallvik M; Nordahl HM
    J Dual Diagn; 2014; 10(2):68-78. PubMed ID: 25392248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Substance use and psychiatric symptoms in subjects referred to the drug addiction services by the prefecture].
    Bizzarri JV; Rucci P; Casalboni D; Randi S; Girelli M; Pojer F; Sbrana A
    Epidemiol Psichiatr Soc; 2007; 16(1):73-8. PubMed ID: 17427607
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services.
    Ogloff JR; Lemphers A; Dwyer C
    Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correctional treatment for co-occurring disorders: results of a national survey.
    Peters RH; LeVasseur ME; Chandler RK
    Behav Sci Law; 2004; 22(4):563-84. PubMed ID: 15282840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diversion on adults with co-occurring mental illness and substance use: outcomes from a national multi-site study.
    Broner N; Lattimore PK; Cowell AJ; Schlenger WE
    Behav Sci Law; 2004; 22(4):519-41. PubMed ID: 15282838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction treatment services and co-occurring disorders: Prevalence estimates, treatment practices, and barriers.
    McGovern MP; Xie H; Segal SR; Siembab L; Drake RE
    J Subst Abuse Treat; 2006 Oct; 31(3):267-75. PubMed ID: 16996389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness.
    Buckley PF
    J Clin Psychiatry; 2006; 67 Suppl 7():5-9. PubMed ID: 16961418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organizational capacity to address co-occurring substance use and psychiatric disorders: assessing variation by level of care.
    Lambert-Harris C; Saunders EC; McGovern MP; Xie H
    J Addict Med; 2013; 7(1):25-32. PubMed ID: 23188042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD; Blank MB; Pithey AL
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central New York Psychiatric Center: an approach to the treatment of co-occurring disorders in the New York State correctional mental health system.
    Smith H; Sawyer DA; Way BB
    Behav Sci Law; 2002; 20(5):523-34. PubMed ID: 12239710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the nation's mental health 2007.
    Henderson S; Andrews G; Hall W
    Aust N Z J Psychiatry; 2009 Jul; 43(7):591-3. PubMed ID: 19530015
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorder.
    Brunette MF; Mueser KT
    J Clin Psychiatry; 2006; 67 Suppl 7():10-7. PubMed ID: 16961419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of psychiatric and substance use disorders among single mothers nearing lifetime welfare eligibility limits.
    Cook JA; Mock LO; Jonikas JA; Burke-Miller JK; Carter TM; Taylor A; Petersen CA; Grey DD; Gruenenfelder D
    Arch Gen Psychiatry; 2009 Mar; 66(3):249-58. PubMed ID: 19255374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.